Human immunodeficiency virus (HIV) Type 1 reverse transcriptase resistance mutations in hepatitis B virus (HBV)-HIV-coinfected patients treated for HBV chronic infection once daily with 10 milligrams of adefovir dipivoxil combined with lamivudine - Delaugerre,C.; Marcelin,A.G.; Thibault,V. (Antimicrob Agents Chemother, 2002)